TOKYO -- With antibody treatments seen as the best weapon against COVID-19, Japan and the country's top drugmaker have turned to a type derived from the plasma of recovered patients, rather than the lab-made varieties used on U.S. President Donald Trump.
Coronavirus
Japan takes different track than US on COVID-19 antibody treatments
Takeda alliance focuses on therapy derived from patients' blood
A researcher holds a test tube of antibodies: Regeneron and Eli Lilly are among the companies developing coronavirus treatments. © Reuters
Read Next
Latest on Coronavirus
